Founded in San Diego, Calif., in 2013, CardioCell LLC is a global biotechnology company that explores therapeutic applications of unique patented ischemia-tolerant mesenchymal stem cells (itMSCs) manufactured under cGMP conditions. CardioCell has an exclusive worldwide license from its parent company, Stemedica, for exploration of therapeutic indications in the cardiovascular field, which includes such indications as acute myocardial Infarction (AMI), chronic heart failure (CHF) and peripheral artery disease (PAD).
|
|
|
|
|
1-10 employees
View all CardioCell employees
|
|
|
Biotechnology Research
|
|
|
(858) 875-6569
|
|
|
San Diego, California
|
|
|
2013
|
The decision makers in CardioCell are Tim Brown, etc. Click to Find CardioCell decision makers emails.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.